drugset / Trial / NCT00003725

Surgery With or Without Chemotherapy in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer

NCT00003725

Phase 3 Unknown 300 enrolled Anthra Pharmaceuticals
RandomizedTreatment

Summary

RATIONALE: Transurethral resection is a less invasive type of surgery for bladder cancer and may have fewer side effects and improve recovery. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known whether transurethral resection plus AD 32 is more effective than transurethral resection alone for bladder cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of transurethral resection surgery followed by AD 32 with that of transurethral resection alone in treating patients who have newly diagnosed or recurrent bladder cancer.

Timeline

Start
1996-12
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Valrubicin Small molecule Other